Controlled clinical trial with Fentiazac cream in sport microtraumatology.
Fentiazac 5% cream was applied topically on limited articular and extra-articular inflammatory lesions in the course of a double-blind clinical trial versus placebo. The drug proved to be satisfactorily tolerated and also therapeutically effective since it changed significantly (p less than 0.05--less than 0.01) the spontaneous course of the microtraumatic pathologic pattern producing an early attenuation and resolution of the painful and functional symptomatic pattern.
D000085:Acetates / Q000008:administration & dosage / Q000627:therapeutic use*; D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D001265:Athletic Injuries / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010919:Placebos; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*
D000085:Acetates; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009824:Ointments; D010919:Placebos; D013844:Thiazoles; C006124:fentiazac